CIK 0000744218 · Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133191702
- Phone
- 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-15 | Marucci Anthony S PRESIDENT & CEO | Sale | −120,000 | $37.66 | $4.5M | 27,692 |
| 2022-08-15 | Wright Richard M. SR. VP & CCO | Sale | −15,328 | $37.71 | $578K | 208 |
| 2022-08-12 | Martin Samuel Bates SVP AND CFO | Sale | −14,261 | $36.76 | $524K | 27,664 |
| 2022-08-12 | Martin Samuel Bates SVP AND CFO | Sale | −2,065 | $35.38 | $73K | 25,599 |
| 2022-08-12 | Martin Samuel Bates SVP AND CFO | Sale | −1,221 | $34.62 | $42K | 24,378 |
| 2022-08-11 | Martin Samuel Bates SVP AND CFO | Sale | −2,453 | $37.04 | $91K | 24,378 |
| 2021-12-23 | Martin Samuel Bates SVP and CFO | Sale | −9,500 | $42.00 | $399K | 24,378 |
| 2021-12-08 | Cavanaugh Sarah SVP of Corp Affairs & Admin. | Sale | −7,323 | $40.00 | $293K | 408 |
| 2021-12-08 | Crowley Elizabeth Sr. VP &CPDO | Sale | −4,000 | $40.00 | $160K | 4,726 |
| 2021-12-08 | Heath-Chiozzi Margo SVP of Regulatory Affairs | Sale | −600 | $40.00 | $24K | 11,247 |
| 2021-11-15 | Martin Samuel Bates SVP and CFO | Sale | −7,452 | $43.92 | $327K | 28,926 |
| 2021-11-15 | Martin Samuel Bates SVP and CFO | Sale | −2,048 | $42.27 | $87K | 26,878 |
| 2021-11-12 | Young Diane C. SVP, Chief Medical Officer | Sale | −4,600 | $42.94 | $198K | 2,115 |
| 2021-11-01 | Cavanaugh Sarah SVP of Corp Affairs & Admin. | Sale | −4,302 | $44.11 | $190K | 3,429 |
| 2021-11-01 | Cavanaugh Sarah SVP of Corp Affairs & Admin. | Sale | −901 | $43.06 | $39K | 2,528 |
| 2021-11-01 | Cavanaugh Sarah SVP of Corp Affairs & Admin. | Sale | −2,120 | $41.62 | $88K | 408 |
| 2021-11-01 | Crowley Elizabeth Sr. VP &CPDO | Sale | −2,528 | $44.12 | $112K | 6,515 |
| 2021-11-01 | Crowley Elizabeth Sr. VP &CPDO | Sale | −600 | $43.11 | $26K | 5,915 |
| 2021-11-01 | Crowley Elizabeth Sr. VP &CPDO | Sale | −1,189 | $41.62 | $49K | 4,726 |
| 2021-11-01 | Heath-Chiozzi Margo SVP of Regulatory Affairs | Sale | −600 | $41.71 | $25K | 11,247 |
Page 2 of 3 · 44 trades